Pharmaessentia Corporation
therapeutic solutions for patients with MPNs and other hematological diseases
Based in MA
🤖
AI Overview
With $275K in lobbying spend across 14 quarterly filings, Pharmaessentia Corporation is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2023.
$275K
Total Spend
3
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $125K |
| 2022 | $40K |
| 2023 | $110K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy
- •FDA inspections
- •FDA Foreign Inspections Backlog
- •Company Drug Approval Updates
- •Intro meeting, offer to visit headquarters
- •H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan'
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.